A Study to Evaluate the Efficacy and Safety of LZM012 ( Psoriasis )
Clinical trial NCT07746479 · COMPLETED
Trial details
- NCT number
- NCT07746479
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-23
- Primary completion
- 2026-01-26
- Enrollment
- 244
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.